Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Development of novel drugs against influenza virus based on synthetic and natural compounds].

Zarubaev VV, Anfimov PM, Shtro AA, Garshinina AV, Meleshkina IA, Karpinskaia LA, Kozeletskaia KN, Kiselev OI.

Vopr Virusol. 2012 Nov-Dec;57(6):30-6. Russian.

PMID:
23477252
2.

Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.

Moorthy NS, Poongavanam V, Pratheepa V.

Mini Rev Med Chem. 2014;14(10):819-30. Review.

PMID:
25342196
3.

[New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].

Shibnev VA, Garayev TM, Finogenova MP, Shevchenko ES, Burtseva EI.

Vopr Virusol. 2011 Mar-Apr;56(2):36-9. Russian.

PMID:
21545040
4.

Antivirals used for influenza chemoprophylaxis.

Tsiodras S, Nikolopoulos G, Bonovas S.

Curr Med Chem. 2012;19(35):5947-56. Review.

PMID:
22963557
5.

Current advances in anti-influenza therapy.

Saladino R, Barontini M, Crucianelli M, Nencioni L, Sgarbanti R, Palamara AT.

Curr Med Chem. 2010;17(20):2101-40. Review.

PMID:
20423307
6.

Influenza virus resistance to antiviral therapy.

van der Vries E, Schutten M, Fraaij P, Boucher C, Osterhaus A.

Adv Pharmacol. 2013;67:217-46. doi: 10.1016/B978-0-12-405880-4.00006-8. Review.

PMID:
23886002
7.

Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.

Zarubaev VV, Golod EL, Anfimov PM, Shtro AA, Saraev VV, Gavrilov AS, Logvinov AV, Kiselev OI.

Bioorg Med Chem. 2010 Jan 15;18(2):839-48. doi: 10.1016/j.bmc.2009.11.047. Epub 2009 Nov 29.

PMID:
20006516
8.

Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus.

Fytas C, Kolocouris A, Fytas G, Zoidis G, Valmas C, Basler CF.

Bioorg Chem. 2010 Dec;38(6):247-51. doi: 10.1016/j.bioorg.2010.09.001. Epub 2010 Sep 21.

9.

Recent progress and challenges in the discovery of new neuraminidase inhibitors.

Chamni S, De-Eknamkul W.

Expert Opin Ther Pat. 2013 Apr;23(4):409-23. doi: 10.1517/13543776.2013.765861. Epub 2013 Feb 1. Review.

PMID:
23369206
10.

Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.

Hurt AC, Ho HT, Barr I.

Expert Rev Anti Infect Ther. 2006 Oct;4(5):795-805. Review.

PMID:
17140356
11.

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.

Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, Payungporn S, Poovorawan Y, Hannongbua S.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):390-4. doi: 10.1016/j.bbrc.2009.05.066. Epub 2009 May 20.

PMID:
19463784
12.

The preventive and therapeutic potential of natural polyphenols on influenza.

Bahramsoltani R, Sodagari HR, Farzaei MH, Abdolghaffari AH, Gooshe M, Rezaei N.

Expert Rev Anti Infect Ther. 2016;14(1):57-80. doi: 10.1586/14787210.2016.1120670. Epub 2015 Dec 7. Review.

PMID:
26567957
13.

Recent advances in computer-aided drug design as applied to anti-influenza drug discovery.

Mallipeddi PL, Kumar G, White SW, Webb TR.

Curr Top Med Chem. 2014;14(16):1875-89. Review.

PMID:
25262796
14.

Influenza chemotherapy: a review of the present state of art and of new drugs in development.

Lüscher-Mattli M.

Arch Virol. 2000;145(11):2233-48. Review.

PMID:
11205114
15.

Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.

Göktaş F, Vanderlinden E, Naesens L, Cesur N, Cesur Z.

Bioorg Med Chem. 2012 Dec 15;20(24):7155-9. doi: 10.1016/j.bmc.2012.09.064. Epub 2012 Oct 12.

PMID:
23117173
16.

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.

Nguyen HT, Fry AM, Gubareva LV.

Antivir Ther. 2012;17(1 Pt B):159-73. doi: 10.3851/IMP2067. Epub 2012 Feb 3. Review.

PMID:
22311680
17.
18.

Recent Patents on development of nucleic acid-based antiviral drugs against seasonal and pandemic influenza virus infections.

Saravolac EG, Wong JP.

Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):140-7. Review.

PMID:
18221170
19.

Adamantane - A Lead Structure for Drugs in Clinical Practice.

Spilovska K, Zemek F, Korabecny J, Nepovimova E, Soukup O, Windisch M, Kuca K.

Curr Med Chem. 2016;23(29):3245-3266. Review.

PMID:
27222266
20.

Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.

An L, Liu R, Tang W, Wu JG, Chen X.

Antiviral Res. 2014 Sep;109:54-63. doi: 10.1016/j.antiviral.2014.06.007. Epub 2014 Jun 24.

PMID:
24971493

Supplemental Content

Support Center